請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/86019
標題: | 雲端藥局-台灣數位醫療新面貌 iPharmacy-The New Trend of Taiwan Digital Health |
作者: | Wei-Chien Hsu 徐維謙 |
指導教授: | 曹承礎(Seng-Cho Chou) 曹承礎(Seng-Cho Chou | chou@ntu.edu.tw | ), |
關鍵字: | 數位醫療,雲端藥局, Pharmacy,Digital Health, |
出版年 : | 2022 |
學位: | 碩士 |
摘要: | 自 2019 年底至今,Covid-19 已在全球範圍內造成混亂。在過去的兩年裡,無論你是誰,無論你住在哪裡,每個人都很難過。沒有人能避免這場流行病。世界衛生組織 (WHO) 和主要的跨國製藥公司急於發明一種治療 covid-19 的方法。在這種情況下,政府和人民更加關注國家的醫療保健產業和發展。 在台灣,國民健康保險 (NHI) 涵蓋大部分醫療費用。據中央社報導,2019年國民健康保險局(NHIA)的處方藥費用超過2000億新台幣,慢性病用藥費用超過800億新台幣,佔整體的40%。與上一年相比,處方藥的成本上漲了 6.5%,並預測未來每年增長 5% 至 8% 的趨勢(Central,2020)。 2017 年 5 月 4 日,NHIA 發布新聞稿,表示台灣遠程醫療服務可以惠及到診所不便或居住在農村的患者和長者。同時,NHIA門診費用比上年降低13%。從新聞稿中可以看出政府對未來數字健康產業發展趨勢的態度和鼓勵(NHIA,2017)。 由於上述市場機遇和政府支持的原因,它提出了創建“Cakinho iPharmacy”品牌的商業計劃,該品牌提供處方交付服務、在線用藥和健康問答服務,並根據臨床情況提供個性化的健康建議。我們的專業藥劑師和營養師的用藥記錄。 這個商業計劃是我和我的合作夥伴的創業公司。幾年前我就有這個想法,但由於台灣的醫療監管保守,我們只能觀察數字醫療市場的趨勢和政府的態度。在 Covid-19 之後情況發生了變化,人們正在尋找數字醫療保健服務,以避免去醫院或診所服用所需的藥物。 以下內容將基於我在政府機構、第三方研究機構對醫療保健行業的研究,以及我過去幾年在生物醫療行業的專業經驗。 Executive Summary Covid-19 has caused chaos all over the world since the end of 2019 until now. For the past two years, it has been difficult for everyone, no matter who you are, or where you live. No one can avoid the pandemic. The World Health Organization (WHO) and the major multinational pharmaceutical companies hurried to invent a cure of the covid-19. Under this circumstance, the government and the people were more aware of the healthcare industries and development in the country. In Taiwan, the National Health Insurance (NHI) covers the majority of the medical treatment payment. According to the Central News Agency, the cost of the prescription drug covered by the National Health insurance Administration (NHIA) in 2019 was over 200 billion NTD, and Chronic Disease medication covered more than 80 billion NTD, which is 40% overall. Comparing the cost of the prescription drug from the previous year it raised 6.5% and predicts the trend growth between 5% to 8% annually in the future (Central, 2020). On 4th May 2017, the NHIA issued a press release of the telemedicine service in Taiwan can benefit patients and elders who are inconvenient to access clinics or who lived in the countryside. At the same time, it decreased the cost of outpatient clinic cost for the NHIA by 13% from the previous year. Based on the press release we could see the attitude and the encouragement of the government facing the trend of digital health industry development in the future (NHIA, 2017). Due to the mentioned reasons in the market opportunity and the government’s support, it prompts a business plan on creating a brand “Cakinho iPharmacy”, which provide prescription delivery service, online medication, and healthcare Q&A service, and personalize healthcare recommendation based on the clinical and medication record by our professional pharmacists and nutritionists. This business plan is a startup for my partners and me. I had this idea several years ago, but due to the conservative healthcare regulation in Taiwan, we could not do anything more besides observing the trend of the digital health market and the attitude of the government. The situation has changed after the Covid-19, people are looking for digital healthcare services to avoid going to hospitals or clinics to fulfill the medication needed. The following content will be based on my research in the healthcare industry from government institutions, third-party research agencies, and my past years’ professional experience in the bio-medical industry. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/86019 |
DOI: | 10.6342/NTU202204129 |
全文授權: | 同意授權(全球公開) |
電子全文公開日期: | 2022-10-20 |
顯示於系所單位: | 管理學院企業管理專班(Global MBA) |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2609202223555300.pdf | 1.91 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。